These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 33285566)

  • 1. Key residues influencing binding affinities of 2019-nCoV with ACE2 in different species.
    Fang S; Zheng R; Lei C; Wang J; Zheng R; Li M
    Brief Bioinform; 2021 Mar; 22(2):963-975. PubMed ID: 33285566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In Silico Prediction of New Mutations That Can Improve the Binding Abilities Between 2019-nCoV Coronavirus and Human ACE2.
    Fang S; Zheng R; Lei C; Wang J; Zhou R; Li M
    IEEE/ACM Trans Comput Biol Bioinform; 2022; 19(3):1694-1702. PubMed ID: 33560990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Silico analysis of interaction between full-length SARS-CoV2 S protein with human Ace2 receptor: Modelling, docking, MD simulation.
    Rui L; Haonan L; Wanyi C
    Biophys Chem; 2020 Dec; 267():106472. PubMed ID: 32916377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative analysis of ACE2 binding to coronavirus spike proteins: SARS-CoV-2
    Li Z; Zhang JZH
    Phys Chem Chem Phys; 2021 Jun; 23(25):13926-13933. PubMed ID: 34137759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular insights into the binding variance of the SARS-CoV-2 spike with human, cat and dog ACE2 proteins.
    Zang Y; Li X; Zhao Y; Wang H; Hao D; Zhang L; Yang Z; Yuan X; Zhang S
    Phys Chem Chem Phys; 2021 Jun; 23(24):13752-13759. PubMed ID: 34132301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diversity of ACE2 and its interaction with SARS-CoV-2 receptor binding domain.
    Low-Gan J; Huang R; Kelley A; Jenkins GW; McGregor D; Smider VV
    Biochem J; 2021 Oct; 478(19):3671-3684. PubMed ID: 34558627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular simulation studies of the interactions between the human/pangolin/cat/bat ACE2 and the receptor binding domain of the SARS-CoV-2 spike protein.
    Ma S; Li H; Yang J; Yu K
    Biochimie; 2021 Aug; 187():1-13. PubMed ID: 33984400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evolutionary Arms Race between Virus and Host Drives Genetic Diversity in Bat Severe Acute Respiratory Syndrome-Related Coronavirus Spike Genes.
    Guo H; Hu BJ; Yang XL; Zeng LP; Li B; Ouyang S; Shi ZL
    J Virol; 2020 Sep; 94(20):. PubMed ID: 32699095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different compounds against Angiotensin-Converting Enzyme 2 (ACE2) receptor potentially containing the infectivity of SARS-CoV-2: an in silico study.
    Shahbazi B; Mafakher L; Teimoori-Toolabi L
    J Mol Model; 2022 Mar; 28(4):82. PubMed ID: 35249180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cervids ACE2 Residues that Bind the Spike Protein can Provide Susceptibility to SARS-CoV-2.
    Lopes LR
    Ecohealth; 2023 Mar; 20(1):9-17. PubMed ID: 37106170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Shedding Light on the Inhibitory Mechanisms of SARS-CoV-1/CoV-2 Spike Proteins by ACE2-Designed Peptides.
    Freitas FC; Ferreira PHB; Favaro DC; Oliveira RJ
    J Chem Inf Model; 2021 Mar; 61(3):1226-1243. PubMed ID: 33619962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural and simulation analysis of hotspot residues interactions of SARS-CoV 2 with human ACE2 receptor.
    Veeramachaneni GK; Thunuguntla VBSC; Bobbillapati J; Bondili JS
    J Biomol Struct Dyn; 2021 Jul; 39(11):4015-4025. PubMed ID: 32448098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular basis for higher affinity of SARS-CoV-2 spike RBD for human ACE2 receptor.
    Delgado JM; Duro N; Rogers DM; Tkatchenko A; Pandit SA; Varma S
    Proteins; 2021 Sep; 89(9):1134-1144. PubMed ID: 33864655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Three salvianolic acids inhibit 2019-nCoV spike pseudovirus viropexis by binding to both its RBD and receptor ACE2.
    Hu S; Wang J; Zhang Y; Bai H; Wang C; Wang N; He L
    J Med Virol; 2021 May; 93(5):3143-3151. PubMed ID: 33580518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Withanone from
    Balkrishna A; Pokhrel S; Singh H; Joshi M; Mulay VP; Haldar S; Varshney A
    Drug Des Devel Ther; 2021; 15():1111-1133. PubMed ID: 33737804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Host range and structural analysis of bat-origin RshSTT182/200 coronavirus binding to human ACE2 and its animal orthologs.
    Hu Y; Liu K; Han P; Xu Z; Zheng A; Pan X; Jia Y; Su C; Tang L; Wu L; Bai B; Zhao X; Tian D; Chen Z; Qi J; Wang Q; Gao GF
    EMBO J; 2023 Feb; 42(4):e111737. PubMed ID: 36519268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanistic Origin of Different Binding Affinities of SARS-CoV and SARS-CoV-2 Spike RBDs to Human ACE2.
    Zhang ZB; Xia YL; Shen JX; Du WW; Fu YX; Liu SQ
    Cells; 2022 Apr; 11(8):. PubMed ID: 35455955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Why are ACE2 binding coronavirus strains SARS-CoV/SARS-CoV-2 wild and NL63 mild?
    Rawat P; Jemimah S; Ponnuswamy PK; Gromiha MM
    Proteins; 2021 Apr; 89(4):389-398. PubMed ID: 33210300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Luteolin inhibits spike protein of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) binding to angiotensin-converting enzyme 2.
    Zhu J; Yan H; Shi M; Zhang M; Lu J; Wang J; Chen L; Wang Y; Li L; Miao L; Zhang H
    Phytother Res; 2023 Aug; 37(8):3508-3521. PubMed ID: 37166054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Critical Sequence Hotspots for Binding of Novel Coronavirus to Angiotensin Converter Enzyme as Evaluated by Molecular Simulations.
    Ghorbani M; Brooks BR; Klauda JB
    J Phys Chem B; 2020 Nov; 124(45):10034-10047. PubMed ID: 33112147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.